0000914475-13-000022.txt : 20130401 0000914475-13-000022.hdr.sgml : 20130401 20130401172642 ACCESSION NUMBER: 0000914475-13-000022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130328 FILED AS OF DATE: 20130401 DATE AS OF CHANGE: 20130401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC CENTRAL INDEX KEY: 0000914475 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330525145 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 617-7600 MAIL ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MITCHELL W THOMAS CENTRAL INDEX KEY: 0001214352 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22705 FILM NUMBER: 13732477 MAIL ADDRESS: STREET 1: 48030 PASO TIEMPO LN CITY: LA QUINTA STATE: CA ZIP: 92253 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-03-28 0000914475 NEUROCRINE BIOSCIENCES INC NBIX 0001214352 MITCHELL W THOMAS 12780 EL CAMINO REAL SAN DIEGO CA 92130 1 0 0 0 Common Stock 2013-03-28 4 M 0 12000 10.60 A 13000 D Common Stock 2013-03-28 4 F 0 10469 12.15 D 2531 D Stock Option 10.60 2013-03-28 4 M 0 12000 0 D 2008-06-30 2013-06-30 Common Stock 12000 0 D The share issuance reported on Table I reflects shares issued upon the exercise of options granted on June 30, 2006, which, if unexercised, would have expired on June 30, 2013. The option exercises are reported on Table II. These option exercises were pursuant to a net issuance arrangement effected under the issuer's equity incentive plan. The number of shares issued pursuant to the net issuance arrangement was calculated as follows: the option exercise price ($10.60) was subtracted from the March 28, 2013 market close price ($12.15), and this net amount ($1.55) was then multiplied by the number of options (12,000), with the resulting amount then divided by the market close price to result in a net issuance of 1,531 shares to the optionee. The 10,469 shares underlying the remaining portion of the options are not available for reissuance, and no shares are sold into the market as part of the exercise in connection with a net issuance program. 1,531 shares are held directly by the Reporting Person; 1,000 shares are held indirectly by The Mitchell Living Trust Margaret E. Valeur-Jensen, By Power of Attorney 2013-04-01